Stent graft maker Lombard Medical makes more space to keep up with demand for its Aorfix device, expanding its U.K. facilities and dumping its non-core businesses.
U.K.-based medical device maker Lombard Medical Technologies (LON:LMT) is doubling down on its flagship Aorfix aortic stent graft technology, dumping its non-core businesses and expanding facilities to meet demand for the device.
Lombard is broadening its R&D and manufacturing facilities in Dicot, Oxfordshire, planning to move its Aorfix business there and leave behind the OEM business in Prestwick, Scotland.
